back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-05 13:26 Tx date 2024-04-05 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$678.59
+7,143 vol $0.095 each |
3,382,500 | |
| Filed 2024-04-05 13:23 Tx date 2024-04-05 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+50,000 vol $0.10 each |
3,375,357 | |
| Filed 2024-03-28 12:10 Tx date 2024-03-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,750
+100,000 vol $0.0975 each |
1,797,857 | |
| Filed 2023-12-12 17:20 Tx date 2023-12-08 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$2,999
+42,857 vol $0.07 each |
3,325,357 | |
| Filed 2023-12-12 09:03 Tx date 2023-12-08 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$2,999
+42,857 vol $0.07 each |
1,677,857 | |
| Filed 2023-12-12 08:55 Tx date 2023-12-12 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+20,000 vol $0.10 each |
1,655,000 | |
| Filed 2023-08-31 13:29 Tx date 2023-08-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,250
+255,000 vol $0.15 each |
950,000 | |
| Filed 2023-08-30 13:22 Tx date 2023-08-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Daugaard, Mads
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+200,000 vol $0.15 each |
1,245,000 | |
| Filed 2023-08-30 11:27 Tx date 2023-08-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Liggett, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
150,000 | |
| Filed 2023-08-30 10:20 Tx date 2023-08-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Langlands, John Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+200,000 vol $0.15 each |
1,245,000 | |
| Filed 2023-08-30 10:16 Tx date 2023-08-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Brown, Dennis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,750
+25,000 vol $0.15 each |
150,000 | |
| Filed 2023-08-30 10:13 Tx date 2023-08-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,250
+335,000 vol $0.15 each |
1,725,000 | |
| Filed 2023-08-30 10:09 Tx date 2023-08-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+200,000 vol $0.15 each |
930,000 | |
| Filed 2023-08-15 13:20 Tx date 2023-08-14 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+50,000 vol $0.10 each |
3,282,500 | |
| Filed 2023-06-29 14:25 Tx date 2023-05-29 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Downstream Holdings Ltd. (Indirect Ownership)
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$1,000,000 vol $0.20 each |
$1,000,000 | |
| Filed 2023-06-29 14:20 Tx date 2019-05-14 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Downstream Holdings Ltd. (Indirect Ownership)
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-29 14:04 Tx date 2023-05-29 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$50,000 vol $0.20 each |
$50,000 | |
| Filed 2023-06-29 13:52 Tx date 2019-05-14 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-07 13:57 Tx date 2023-05-29 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Downstream Holdings Ltd. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+2,000,000 vol |
2,000,000 | |
| Filed 2023-06-07 13:55 Tx date 2019-05-14 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Downstream Holdings Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-07 13:43 Tx date 2023-05-29 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+100,000 vol |
100,000 | |
| Filed 2023-06-07 13:38 Tx date 2019-05-14 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-07 11:14 Tx date 2023-05-30 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+100,000 vol |
162,500 | |
| Filed 2023-06-07 09:39 Tx date 2023-05-30 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$50,000 vol $0.20 each |
$50,000 | |
| Filed 2023-06-07 09:37 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-07 09:36 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-07 09:29 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-13 10:01 Tx date 2023-02-09 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+50,000 vol $0.14 each |
1,635,000 | |
| Filed 2023-02-09 14:08 Tx date 2023-02-08 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+75,000 vol $0.12 each |
3,232,500 | |
| Filed 2023-01-19 16:59 Tx date 2023-01-18 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,143
+70,000 vol $0.1449 each |
315,000 | |
| Filed 2023-01-19 16:55 Tx date 2023-01-18 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,396
+60,000 vol $0.1566 each |
1,585,000 | |
| Filed 2022-12-28 15:27 Tx date 2022-12-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Langlands, John Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+50,000 vol $0.18 each |
||
| Filed 2022-12-28 15:23 Tx date 2022-12-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Langlands, John Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+50,000 vol $0.18 each |
50,000 | |
| Filed 2022-12-28 15:20 Tx date 2022-12-28 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Langlands, John Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+50,000 vol $0.18 each |
||
| Filed 2022-12-28 15:18 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Langlands, John Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-19 16:39 Tx date 2022-10-18 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+50,000 vol $0.18 each |
245,000 | |
| Filed 2022-10-03 11:52 Tx date 2022-10-03 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Daugaard, Mads
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+50,000 vol $0.18 each |
100,000 | |
| Filed 2022-09-30 12:57 Tx date 2022-09-29 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,500
+50,000 vol $0.17 each |
3,157,500 | |
| Filed 2022-09-30 11:56 Tx date 2022-09-29 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+50,000 vol $0.21 each |
1,525,000 | |
| Filed 2022-09-16 10:35 Tx date 2022-09-14 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,500
+50,000 vol $0.17 each |
1,475,000 | |
| Filed 2022-09-15 12:58 Tx date 2022-09-14 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-700,000 vol |
3,107,500 | |
| Filed 2022-09-15 12:56 Tx date 2022-09-14 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sequel Consulting Services Ltd. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+700,000 vol |
1,642,500 | |
| Filed 2022-06-03 10:38 Tx date 2022-06-03 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,242
+70,000 vol $0.1606 each |
195,000 | |
| Filed 2022-06-01 15:51 Tx date 2022-06-01 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,770
+50,000 vol $0.1554 each |
1,425,000 | |
| Filed 2022-04-08 15:01 Tx date 2022-04-07 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sequel Consulting Services Ltd. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+350,000 vol |
942,500 | |
| Filed 2022-04-08 14:59 Tx date 2022-04-07 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-350,000 vol |
3,807,500 | |
| Filed 2022-04-08 14:54 Tx date 2021-10-08 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-357,500 vol |
4,157,500 | |
| Filed 2021-11-18 12:00 Tx date 2021-11-16 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$250,000
+1,250,000 vol $0.20 each |
1,375,000 | |
| Filed 2021-11-18 11:52 Tx date 2021-11-16 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Brown, Dennis
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$125,000
+625,000 vol $0.20 each |
625,000 | |
| Filed 2021-11-18 11:51 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Brown, Dennis
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-18 11:46 Tx date 2021-11-16 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
NewGen Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,146,875
-5,734,375 vol $0.20 each |
24,265,625 | |
| Filed 2021-10-12 12:53 Tx date 2021-10-08 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sequel Consulting Services Ltd. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+357,500 vol |
592,500 | |
| Filed 2021-07-26 14:28 Tx date 2021-03-24 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Liggett, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+125,000 vol $0.20 each |
125,000 | |
| Filed 2021-07-26 14:26 Tx date 2021-03-31 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Liggett, Michael
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-18 13:33 Tx date 2021-04-21 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sequel Consulting Services Ltd. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+235,000 vol |
235,000 | |
| Filed 2021-05-18 13:31 Tx date 2021-04-21 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-235,000 vol |
4,515,000 | |
| Filed 2021-05-18 13:25 Tx date 2019-05-14 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sequel Consulting Services Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-07 19:16 Tx date 2021-03-31 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Langlands, John Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,045,000 vol |
1,045,000 | |
| Filed 2021-04-07 19:10 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Langlands, John Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-06 10:19 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
NewGen Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
30,000,000 | ||
| Filed 2021-04-05 21:34 Tx date 2021-03-31 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Brown, Dennis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
125,000 | |
| Filed 2021-04-05 21:33 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Brown, Dennis
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-05 19:16 Tx date 2021-03-31 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Cherrington, Julie Michele
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
125,000 | |
| Filed 2021-04-05 19:15 Tx date 2021-03-31 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Cherrington, Julie Michele
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-05 17:13 Tx date 2021-04-05 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Cherrington, Julie Michele
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
125,000 | |
| Filed 2021-04-05 17:13 Tx date 2021-04-05 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Cherrington, Julie Michele
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
||
| Filed 2021-04-05 17:13 Tx date 2021-04-05 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Cherrington, Julie Michele
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-05 17:13 Tx date 2021-04-05 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Cherrington, Julie Michele
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-05 17:12 Tx date 2021-04-05 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Cherrington, Julie Michele
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-05 17:07 Tx date 2021-04-05 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Cherrington, Julie Michele
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-05 10:27 Tx date 2021-04-01 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Daugaard, Mads
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,045,000 vol |
1,045,000 | |
| Filed 2021-04-05 10:25 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Daugaard, Mads
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-05 10:24 Tx date 2021-04-01 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+730,000 vol |
730,000 | |
| Filed 2021-04-05 10:23 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-05 10:17 Tx date 2021-04-01 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,390,000 vol |
1,390,000 | |
| Filed 2021-04-05 10:13 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-02 17:58 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Daugaard, Mads
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2021-04-02 17:57 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Daugaard, Mads
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2021-04-02 14:48 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
62,500 | ||
| Filed 2021-04-02 14:48 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2021-04-01 18:22 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
62,500 | ||
| Filed 2021-04-01 18:21 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2021-03-29 18:01 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Colangelo, Benito James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+250,000 vol $0.10 each |
750,000 | |
| Filed 2021-03-29 18:00 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Colangelo, Benito James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-250,000 vol $0.10 each |
0 | |
| Filed 2021-03-29 17:46 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Grande, Maurizio
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$40,000,000,000
+200,000 vol $200,000 each |
1,200,000 | |
| Filed 2021-03-29 17:43 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
Grande, Maurizio
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-20,000
-200,000 vol $0.10 each |
0 | |
| Filed 2021-03-29 15:49 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$139,000
+695,000 vol $0.20 each |
695,000 | |
| Filed 2021-03-29 15:47 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$562,500,000,000
+750,000 vol $750,000 each |
4,750,000 | |
| Filed 2021-03-29 15:46 Tx date 2021-03-25 |
$RKV
Rakovina Therapeutics Inc. (formerly, Vincero Capital Corp.) |
De Lucrezia, Alfredo
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-75,000
-750,000 vol $0.10 each |
0 |